Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles
and cell cycle arrest of MLL-AF6-transformed cells
SAR 439859
IPA-3 reversibly inhibits PMA-induced membrane ruffling in cells
AMG 837 increases insulin release when glucose levels are elevated
PF-562271 besylate - CAS# 939791-38-5 aminophen metabolite 3-hydroxy-acetaminophen Enhanced solubility and functionality ofPF 562271 Besylate, also known as PF 562,271 and PF 271, is an orally bioavailable small molecule and ATP competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities. PF 562271 inhibits the tyrosine kinase FAK, and to a lesser extent, proline rich tyrosine kinase (PYK2), which may inhibit tumor cell migration, proliferation, and survival. Note: PF 562271 benzesulfonate is also called PF 562271
US$ 703.91
US$ 180.50
US$ 19.95
US$ 149.00
US$ 12.35
US$ 13.95
US$ 14.95
US$ 40.95
US$ 66.99